Werner Frantsits, Chief Executive Officer / Chief Financial Officer | | Werner Frantsits, founder and for many years CEO of SANOCHEMIA Pharmazeutika AG, again took up the position of Chief Executive Officer in September 2009, a role in which he is also responsible for the Group's financial affairs. | | |
Maria Popova, member of the Board of Management responsible for Sales and Marketing and Business Development | Maria Popova, since late 2007 at SANOCHEMIA, has a long and well-proven track record following her activities at a research institute and positions at several major pharmaceutical companies | |
Stefan Welzig, Chief Technical Officer Stefan Welzig will assume the position of CTO after Anton Dallos will be leaving the employ of the company with effect from 31.12.2011 because of attainment of retirement age. Having worked for Sanochemia for over 13 years Stefan Welzig already holds the position of director under trade law. | |
Klaus Gerdes, Chief Operating Officer | Klaus Gerdes, since 2006 at Sanochemia, has already headed the departments of New Business Development and R&D.
In addition to his previous responsibilities Klaus Gerdes will also be in charge of Investor Relations. | |
|
| |
